Head and neck cancer trials in Israel

In Israel 13 Also abroad 940

13 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Where
Ashdod, Haifa, Jerusalem, Tel Aviv
Age
60 years and over
People
500 worldwide
Run by
Johnson & Johnson Enterprise Innovation Inc.
See details and how to joinNCT04892173 · EU 2024-520386-31-00
Phase 2/3Taking people
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Where
Beersheba, Jerusalem, Petah Tikva, Tel Aviv
Age
18 years and over
People
650 worldwide
Run by
Bicara Therapeutics
See details and how to joinNCT06788990 · EU 2024-519654-37-00
Phase 1Taking people
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
325 worldwide
Run by
AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Beersheba, Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tsrifin
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
No phaseTaking people
Energy Expenditure Assessment in Head and Neck Cancer Patients Treated With Free Flap Surgery
Where
Tel Aviv
Age
18 years to 120 years
People
19
Run by
Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07759193
Phase 1Taking people
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
Where
Haifa, Jerusalem, Ramat Gan
Age
18 years and over
People
220 worldwide
Run by
AbbVie
See details and how to joinNCT07241039 · EU 2025-521607-48-00
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Haifa, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1Taking people
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Where
Beer Ya'akov, Haifa, Jerusalem, Kefar Sava, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
694 worldwide
Run by
AbbVie
See details and how to joinNCT05005403
No phaseTaking people
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Where
Jerusalem
Age
18 years and over
People
56
Run by
Alpha Tau Medical LTD.
See details and how to joinNCT04534127
Phase 1Taking people
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Where
Jerusalem, Petah Tikva, Ramat Gan
Age
18 years and over
People
248 worldwide
Run by
Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00
Phase 3Taking people
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Where
Ashdod, Haifa, Jerusalem, Tel Aviv
Age
18 years and over
People
864 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00
No phaseTaking people
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
Where
Jerusalem, Ramat Gan, Tel Aviv
Age
18 years and over
People
48
Run by
Alpha Tau Medical LTD.
See details and how to joinNCT05047094
No phaseTaking people
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
Where
Haifa
Age
18 years and over
People
30
Run by
Alpha Tau Medical LTD.
See details and how to joinNCT03889899